Drug Shortage Report for ILEVRO

Last updated on 2022-10-17 History
Report ID 162289
Drug Identification Number 02411393
Brand name ILEVRO
Common or Proper name ILEVRO 0.3% SUSP. 3ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) NEPAFENAC
Strength(s) 0.3%
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 3ML
ATC code S01BC
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-07-05
Actual start date 2022-07-05
Estimated end date 2022-10-14
Actual end date 2022-10-14
Shortage status Resolved
Updated date 2022-10-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2022-10-17 French Compare
v18 2022-10-17 English Compare
v17 2022-09-07 French Compare
v16 2022-09-07 English Compare
v15 2022-08-29 French Compare
v14 2022-08-29 English Compare
v13 2022-08-22 French Compare
v12 2022-08-22 English Compare
v11 2022-08-04 French Compare
v10 2022-08-04 English Compare
v9 2022-07-14 French Compare
v8 2022-07-14 English Compare
v7 2022-07-14 English Compare
v6 2022-07-06 English Compare
v5 2022-06-29 French Compare
v4 2022-06-29 English Compare
v3 2022-06-16 English Compare
v2 2022-06-09 French Compare
v1 2022-06-09 English Compare

Showing 1 to 19 of 19